Circulating inflammation-related markers for the detection of early-stage gastric cancer

Ended Purchase Order Awarded Last action

Contract number
HHSN261201700033A
Awardee
Awarding agency
Obligated
$0

Award facts

Opportunity
Contract value
$0.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
NAICS code
541380 Testing Laboratories and Services
PSC
Q301 Reference Laboratory Testing
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Sweden

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00001 · To DE-obligate funds from FY2017 expiring lines in accordance with NIH oalm communication 22-86 -$70,200
Original award $70,200

Quick answers

Who was awarded contract HHSN261201700033A?

HHSN261201700033A was awarded to Olink Bioscience AB by National Cancer Institute (National Institutes of Health) on August 1, 2017.

How much is contract HHSN261201700033A worth?

The government has obligated $0 on HHSN261201700033A.

Was contract HHSN261201700033A competed?

The extent of competition for HHSN261201700033A was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award